Premawardhena A, Fisher C A, Olivieri N F, de Silva S, Arambepola M, Perera W, O'Donnell A, Peto T E A, Viprakasit V, Merson L, Muraca G, Weatherall D J
National Thalassaemia Centre, General Hospital, Kurunegala, Sri Lanka.
Lancet. 2005;366(9495):1467-70. doi: 10.1016/S0140-6736(05)67396-5.
Haemoglobin E beta thalassaemia is the commonest form of severe thalassaemia in many Asian countries, but little is known about its natural history, the reasons for clinical diversity, or its management. We studied 109 Sri Lankan patients with the disorder over 5 years. 25 patients were not receiving transfusion; transfusion was stopped with no deleterious effect in a further 37. We identified several genetic and environmental factors that might contribute to the phenotypic diversity of the disorder, including modifiers of haemoglobin F production, malaria, and age-related changes in adaptive function. Our findings suggest that haemoglobin E beta thalassaemia can be managed without transfusion in many patients, even with low haemoglobin levels. Age-related changes in the pattern of adaptation to anaemia suggest that different and more cost-effective approaches to management should be explored.
血红蛋白Eβ地中海贫血是许多亚洲国家最常见的严重地中海贫血形式,但对其自然病史、临床多样性的原因或治疗方法知之甚少。我们对109名患有该疾病的斯里兰卡患者进行了为期5年的研究。25名患者未接受输血;另有37名患者停止输血后未产生有害影响。我们确定了几个可能导致该疾病表型多样性的遗传和环境因素,包括血红蛋白F产生的调节因子、疟疾以及适应性功能的年龄相关变化。我们的研究结果表明,即使血红蛋白水平较低,许多患者的血红蛋白Eβ地中海贫血也可以不通过输血进行治疗。贫血适应模式的年龄相关变化表明,应该探索不同的、更具成本效益的治疗方法。